<DOC>
	<DOCNO>NCT02702115</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability ascend dos SB-318 . SB-318 intravenously deliver Zinc Finger Nuclease ( ZFN ) Therapeutic genome editing . It insert correct copy α-L-iduronidase ( IDUA ) gene Albumin locus hepatocytes goal lifelong therapeutic production IDUA enzyme .</brief_summary>
	<brief_title>Ascending Dose Study Genome Editing Zinc Finger Nuclease ( ZFN ) Therapeutic SB-318 Subjects With MPS I</brief_title>
	<detailed_description>The objective study provide long term expression IDUA improve current clinical outcome enzyme replacement therapy ( ERT ) hematopoietic stem cell transplantation ( HSCT ) therapy subject attenuate MPS I , recessive lysosomal storage disorder result mutation gene encode IDUA . SB-318 therapeutic ZFN-mediated genome edit deliver adeno-associated virus ( AAV ) -derived vector . SB-318 intended function placement corrective copy IDUA transgene genome subject 's hepatocytes , control highly express endogenous albumin locus , expect provide permanent , liver-specific expression iduronidase lifetime MPS I patient .</detailed_description>
	<criteria>Male female &gt; 18 year age Clinical diagnosis attenuate MPS I deficiency ( HurlerScheie , Scheie , Hurlers status postHSCT ) Known unresponsive ERT Neutralizing antibody AAV 2/6 Serious intercurrent illness clinically significant organic disease ( unless secondary MPS I ) Receiving antiviral therapy hepatitis B C , active hepatitis B hepatitis C HIV 1/2 Lack tolerance laronidase treatment significant IARs occurrence anaphylaxis Markers hepatic dysfunction Creatinine ≥ 1.5 mg/dL Contraindication use corticosteroid immunosuppression Current treatment systemic ( IV oral ) immunomodulatory agent steroid use ( topical treatment allow ) Participation prior investigational drug medical device study within previous 3 month Prior treatment gene therapy product Elevated abnormal circulate αfetoprotein ( AFP )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>gene specific target insertion</keyword>
</DOC>